FDA issued a Warning Letter to Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on 7/9/2014 as a result of this inspection.
483 Zhejiang Jiuzhou Pharmaceutical Oct 2013

483 Zhejiang Jiuzhou Pharmaceutical Oct 2013

Justin Boyd FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Jiuzhou Pharmaceutical - Taizhou, China facility and issued inspectional observations (via FDA 483) on 24 Oct 2013.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Inspection end: 24 Oct 2013
  • Location: Taizhou, China
  • FEI: 3003744377
Add To Cart